Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications
January 02 2018 - 7:05AM
Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:RDUS)
announced today that Elhan Webb has joined the Company as Head of
Investor Relations and External Communications.
“We are very fortunate to have someone of Elhan’s caliber to
drive our Investor Relations strategy during a pivotal time in the
evolution of Radius,” said Jesper Høiland, President and Chief
Executive Officer of Radius Health. “Elhan’s considerable global
experience in working with both sell-side and buy-side analysts as
well as her experience as an investment portfolio manager uniquely
position her to head Radius’ Investor Relations program.”
Ms. Webb is a CFA® charterholder and joins Radius from
Genfit Corporation where she was Vice President and Head of
Investor Relations. During her diverse international career, she
established a reputation as a forward-thinking investor relations
strategist, business development leader, and investment portfolio
manager at global companies. She spent more than a decade in
Europe managing and leading investments in the healthcare sector at
financial institutions such as BB Biotech-Bellevue Asset
Management, UBS and Lombard Odier. At Roche Group, she led
investor relations activities for Roche Diagnostics, the world's
largest in-vitro diagnostics player. She also held business
development roles at Roche Molecular Diagnostics, U.S. and
Morphochem.
About Radius
Radius is a science-driven fully integrated biopharmaceutical
company that is committed to developing and commercializing
innovative therapeutics in the areas of osteoporosis, oncology and
endocrine diseases. For more information, visit
www.radiuspharm.com, and follow us on Twitter and LinkedIn.
Investor & Media Relations Contact:
Elhan WebbEmail: ewebb@radiuspharm.comPhone: 617-551-4011
Radius Recycling (NASDAQ:RDUS)
Historical Stock Chart
From Apr 2024 to May 2024
Radius Recycling (NASDAQ:RDUS)
Historical Stock Chart
From May 2023 to May 2024